| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/31/1991 | EP0438600A1 Enzymes which participate in c-terminal amidation, and production and use thereof |
| 07/31/1991 | EP0438402A1 Panel of separate peptides |
| 07/31/1991 | CN1053445A Isolation of alpha 1-antitrypsin from human plasma and construction of kit useful for detecting alpha 1-antitrypsin levels in blood |
| 07/30/1991 | US5036053 Diol-containing renin inhibitors |
| 07/30/1991 | US5035999 Aminoluciferin derivatives, processes for the production thereof and their application in the determination of enzyme activities |
| 07/30/1991 | CA1286989C Immunoamplifiers and related compositions |
| 07/27/1991 | CA2034768A1 Recombinant coccidiosis vaccines - 5-7 eimeria surface antigen |
| 07/25/1991 | WO1991010426A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/25/1991 | DE4001238A1 Verfahren zur anreicherung bzw. reinigung von biomolekuelen A method for enrichment or purification of biomolecules |
| 07/24/1991 | EP0483143A4 Membrane affinity apparatus and purification methods related thereto. |
| 07/24/1991 | EP0438259A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/24/1991 | EP0437958A1 Method for heat treatment of lactoferrin without losing physiological activities thereof |
| 07/24/1991 | EP0437687A2 Process for purification of a 69000 dalton antigenic protein from bordetella pertussis |
| 07/24/1991 | EP0437505A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 07/24/1991 | EP0437427A1 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
| 07/24/1991 | EP0259396B1 Process for peptide production |
| 07/24/1991 | CN1053265A Human c3b/c4b receptor (cr1) |
| 07/24/1991 | CA2008438A1 Peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same |
| 07/23/1991 | WO1991010678A1 Method for recovering recombinant proteins |
| 07/23/1991 | US5034516 Synthetic antigens of sialic acid and derivatives thereof |
| 07/23/1991 | US5034511 Variant of LAV viruses |
| 07/23/1991 | CA2074250A1 Method for recovering recombinant proteins |
| 07/23/1991 | CA1286843C Purification method for proteins |
| 07/23/1991 | CA1286696C Automatic process for purifying physiologically active substance, apparatus for the same, and carrier with proteinaceous ligand fixed theretoto be used for the same |
| 07/20/1991 | WO1991010683A1 A platelet cell adhesion molecule and variants thereof |
| 07/20/1991 | CA2074072A1 Platelet cell adhesion molecule and variants thereof |
| 07/20/1991 | CA2023561A1 Platelet cell adhesion molecule and variants thereof |
| 07/19/1991 | WO1991010677A1 Process for enriching or cleaning biomolecules |
| 07/19/1991 | CA2067790A1 Process for enriching or cleaning biomolecules |
| 07/17/1991 | WO1991010742A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/17/1991 | EP0436612A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
| 07/17/1991 | CN1053068A Separation of fat-carried protein a1 and a2 by high-pressure liq. chromatography |
| 07/17/1991 | CA2073060A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/16/1991 | US5032675 Process for the production of glutamine derivatives |
| 07/16/1991 | US5032574 Novel antimicrobial peptide |
| 07/16/1991 | US5032518 Hapten-protein conjugates and the use therof |
| 07/16/1991 | CA1286242C Mutual separation of proteins |
| 07/11/1991 | WO1991010129A1 A protein purification system based on isoelectric focusing and isotachophoresis |
| 07/11/1991 | WO1991009952A1 Lipoprotein signal peptide fused to antigenic polypeptides |
| 07/11/1991 | WO1991009876A1 Radiolabeled proteins for diagnostic or therapeutic use |
| 07/11/1991 | WO1991009872A2 Hiv-1 env fragment fusion protein |
| 07/11/1991 | WO1991009868A1 Amino acid thiohydantoin method and reagent |
| 07/11/1991 | WO1991009615A1 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 07/11/1991 | WO1991009613A1 Synthetic peptides as modulators of functional responses of intact cells |
| 07/10/1991 | EP0436508A2 Mutant microorganisms useful for cleavage of organic C-S bonds |
| 07/10/1991 | EP0436266A1 Process for the production of gelatin from fish skins |
| 07/10/1991 | EP0436086A1 Isolation of alpha-1-antitrypsin from human plasma and construction of a kit useful for detecting alpha 1-antitrypsin levels in blood |
| 07/10/1991 | EP0435946A1 Methods for modifying the binding of cell adhesion receptors. |
| 07/10/1991 | EP0218622B1 Amides of para-methoxycinnamic and utilization thereof as solar filters |
| 07/09/1991 | WO1991010684A1 Oxidized variants of gm-csf |
| 07/09/1991 | US5030716 Methods and compositions employing interferon-gamma |
| 07/09/1991 | US5030715 Antibacterial agents; immunomodulators; auto immune diseases |
| 07/09/1991 | CA2072587A1 Oxidized variants of gm-csf |
| 07/06/1991 | WO1991009874A1 Novel fibronectin receptor |
| 07/06/1991 | CA2072013A1 Fibronectin receptor |
| 07/06/1991 | CA2032937A1 Mutant microorganisms useful for cleavage of organic c-s bonds |
| 07/03/1991 | EP0435503A1 Improvements in or relating to gylcopeptide derivatives |
| 07/03/1991 | EP0434979A1 Peptide derivatives useful as antagonists of bombesin and gastrin-releasing peptide |
| 07/03/1991 | EP0434909A2 Anticoagulant and antihelminthic proteins and methods for the production and use of same |
| 07/03/1991 | EP0434836A1 Method for purifying tenascin |
| 07/03/1991 | EP0434744A1 Serum immunoregulatory polypeptide and uses therefor. |
| 07/03/1991 | EP0434722A1 New pentapeptide and a process for the preparation thereof |
| 07/03/1991 | EP0434718A1 Peptide compounds |
| 07/03/1991 | EP0434708A1 Process for producing dipeptides from non-proteinogenic amino acids with terminal nitrogen atoms. |
| 07/03/1991 | EP0434685A1 Gram-negative bacterial endotoxin blocking monoclonal antibodies |
| 07/02/1991 | US5028697 Antitumor agents, cell specific |
| 07/02/1991 | US5028696 Separation/purification of monoclonal antibodies/proteins |
| 07/02/1991 | US5028693 Urethane-protected amino acid-N-carboxyanhydrides |
| 07/02/1991 | US5028626 Peptides with pharmaceutical activity |
| 07/02/1991 | US5028589 Aliments For Dietetic Or Therapeutic Nutrition |
| 07/02/1991 | US5028587 Containing arg-b31 and/or arg2-(b31-32) human insulin; antidiabetic agents |
| 07/02/1991 | US5028424 Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells |
| 07/02/1991 | US5028420 Muteins of tumor necrosis factor |
| 07/02/1991 | CA1285699C Process for solubilization, purification and characterization ofprotein from insoluble protein aggregates or complexes and compositions of matter therefrom |
| 07/02/1991 | CA1285698C Process for the preparation of compounds containing carboxamide groups,in particular of peptides |
| 07/02/1991 | CA1285507C Hybrid interferons |
| 06/30/1991 | WO1991009877A1 Method of covalently bonding proteins to hydrophilic surfaces |
| 06/30/1991 | CA2072747A1 Method of covalently bonding proteins to hydrophilic surfaces |
| 06/27/1991 | WO1991009060A1 Proteinase inhibitory agents and methods for their use |
| 06/27/1991 | WO1991009052A1 Chromogenic substrate |
| 06/27/1991 | WO1991008762A1 Production of biologically active platelet-derived growth factor from high expression host cell systems |
| 06/27/1991 | DE3942580A1 Verfahren zur herstellung von hirudin A process for the preparation of hirudin |
| 06/27/1991 | CA2032914A1 Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides |
| 06/26/1991 | EP0434605A2 Novel process for the production of unfused protein in E. coli |
| 06/26/1991 | EP0434354A1 Separation material for blood coagulation factor, preparation and use thereof |
| 06/26/1991 | EP0434317A1 Immunoadsorbents |
| 06/26/1991 | EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 06/26/1991 | EP0433744A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration |
| 06/26/1991 | EP0433442A1 Hybrid molecules |
| 06/26/1991 | EP0433395A1 Stable bioactive somatotropins |
| 06/26/1991 | EP0433360A1 Improvements relating to the production of prodrugs. |
| 06/26/1991 | EP0433345A1 Peptide synthesis method and solid support for use in the method. |
| 06/26/1991 | CN1052483A Improvements in or relating to glycopeptide derivatives |
| 06/25/1991 | US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
| 06/25/1991 | US5026773 Apparatus for a solid phase synthesis of peptide analogs |
| 06/25/1991 | US5026639 Method to improve mRNA translation and use thereof for production of platelet factor-4 |
| 06/23/1991 | WO1991009946A1 Method of preparation of hirudin |
| 06/23/1991 | WO1991009945A1 Neutrophil chemoattractants |
| 06/23/1991 | CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 06/23/1991 | CA2072012A1 Neutrophil chemoattractants |